Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
250,783,992
-
Shares change
-
+19,231,413
-
Total reported value, excl. options
-
$3,410,473,734
-
Value change
-
+$284,627,731
-
Put/Call ratio
-
37%
-
Number of buys
-
108
-
Number of sells
-
76
-
Price
-
$13.60
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q1 2019
As of 31 Mar 2019 AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) had 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 250,783,992 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, Redmile Group, LLC, BlackRock Inc., FMR LLC, JANUS HENDERSON GROUP PLC, Avoro Capital Advisors LLC, STATE STREET CORP, JENNISON ASSOCIATES LLC, and WELLINGTON MANAGEMENT GROUP LLP.
This table shows 198 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.